using a double-blind crossover design , we studied the effect of tolazamide , an orally administered sulfonylurea , in 11 patients with non-insulin-dependent diabetes mellitus , poorly controlled on 40 units/day or more of insulin ;
C0040372
tolazamide
C0038766
sulfonylurea